Cell Therapy News Volume 23.06 | Feb 28 2022

    0
    28







    2022-02-28 | CTN 23.06


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.06 – 28 February, 2022
    TOP STORY

    A Combined Cell and Gene Therapy Approach for Homotopic Reconstruction of Midbrain Dopamine Pathways Using Human Pluripotent Stem Cells

    Researchers showed that viral delivery of GDNF to the striatum, in conjunction with homotopic transplantation of human pluripotent stem cell-derived midbrain dopamine (mDA) neurons, recapitulated brain-wide mDA target innervation.
    [Cell Stem Cell]

    AbstractGraphical Abstract
    Register now for the Onco Cell Therapy Summit.
    PUBLICATIONSRanked by the impact factor of the journal

    Rapid Manufacturing of Non-Activated Potent CAR T Cells

    Scientists showed that functional CAR T cells could be generated within 24 hours from T cells derived from peripheral blood without the need for T cell activation or ex vivo expansion
    .
    [Nature Biomedical Engineering]

    Full Article

    Incidence and Management of CAR-T Neurotoxicity in Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel in CARTITUDE Studies

    In CARTITUDE-1, 5% of patients with multiple myeloma reported movement and neurocognitive treatment-emergent adverse events with ciltacabtagene autoleucel, a B cell maturation antigen-targeted CAR T cell therapy.
    [Blood Cancer Journal]

    Full Article

    Increased Visceral Fat Distribution and Body Composition Impact Cytokine Release Syndrome Onset and Severity after CD19 CAR-T in Advanced B Cell Malignancies

    Researchers studied the influence of anthropometric and body composition measurements on CAR-T-related immunotoxicity in 64 patients receiving CD19-directed CAR-T for relapsed/refractory B cell malignancies.
    [Haematologica]

    Abstract

    Early Vascular Toxicity after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation

    The authors evaluated the prevalence of key vascular complications and graft-versus-host disease among 122 pediatric patients with an allogeneic hematopoietic stem cell transplantation between 2001 and 2013.
    [Bone Marrow Transplantation]

    Full Article

    Tacrolimus-Resistant SARS-CoV-2-Specific T Cell Products to Prevent and Treat Severe COVID-19 in Immunosuppressed Patients

    Scientists proposed adoptive transfer of SARS-CoV-2-specific T cells made resistant to a common immunosuppressant, Tacrolimus, for optimized performance in the immunosuppressed patient.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticleGraphical Abstract

    A Novel TanCAR Targeting IL13Rα2 and EphA2 for Enhanced Glioblastoma Therapy

    To improve CAR-T therapy for glioblastoma, a new TanCAR, comprising the tandem arrangement of IL13 and EphA2 scFv, was generated and validated in vitro and in vivo.
    [Molecular Therapy-Oncolytics]

    AbstractFull ArticleGraphical Abstract

    Feasibility Study of a Novel Preparation Strategy for Anti-CD7 CAR-T Cells with a Recombinant Anti-CD7 Blocking Antibody

    The authors reported a new strategy of blocking the CD7 antigen on the T cell surface with a recombinant anti-CD7 antibody to obtain a sufficient amount of CD7-targeting CAR-T cells for T cell acute lymphoblastic leukemia treatment.
    [Molecular Therapy-Oncolytics]

    AbstractFull ArticleGraphical Abstract

    Identification of Genomic Signatures in Bone Marrow Associated with Clinical Response of CD19 CAR T Cell Therapy

    In patients achieving a complete response transcriptomic profiles of bone marrow prior to lymphodepletion showed genes mainly involved in T cell activation.
    [Scientific Reports]

    Full Article

    Stromal-Vascular Fraction and Adipose-Derived Stem Cell Therapies Improve Cartilage Regeneration in Osteoarthritis-Induced Rats

    The macroscopic view and histological sections revealed that the articular cartilage in the normal saline group was damaged, inflamed, uneven and thin, and had hyperchromatic cell infiltration.
    [Scientific Reports]

    Full Article
    Scientific resources to support your stem cell research. Learn More!
    REVIEWS

    Harnessing the Chemokine System to Home CAR-T Cells into Solid Tumors

    By harnessing the chemokine system and taking into consideration the chemokine expression profile in the tumor microenvironment, CAR-T cells may be homed into tumors to facilitate direct tumor cell cytolysis.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    CAR-Based Therapies: Opportunities for Immuno-Medicine beyond Cancer

    Scientists discuss recent studies and emerging research aimed to extend CAR-based therapies beyond oncology in areas such as cardiometabolic disorders, autoimmunity, fibrosis and senescence.
    [Nature Metabolism]

    Abstract
    INDUSTRY AND POLICY NEWS

    Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

    Fluidigm Corporation announced a collaboration agreement with the Abu Dhabi Stem Cells Center for development of targeted stem cell therapies and research applications utilizing two Fluidigm® mass cytometry and tissue imaging technologies.
    [Fluidigm Corporation]

    Press Release

    FDA Grants Orphan Drug Designation to Natural Killer Cell Therapy for GI Cancers

    The FDA granted orphan drug designation to CYNK-101, an investigational natural killer cell-based therapy for treatment of advanced HER2/neu-positive gastric or gastroesophageal junction adenocarcinoma.
    [Healio]

    Press Release

    Wisconsin Partnership Program Announces $600,000 In Research Awards For Early-Career Faculty

    The Wisconsin Partnership Program at the University of Wisconsin School of Medicine and Public Health announced four new awards totaling $600,000 to the school’s faculty through its New Investigator Program.
    [University of Wisconsin School of Medicine and Public Health]

    Press Release

    City of Hope Awarded $4.9 Million from CIRM for Stem Cell Research Training

    City of Hope’s Department of Stem Cell Biology and Regenerative Medicine has received a $4.9 million grant to train the next generation of scientific leaders in basic stem cell research and its translation into novel, lifesaving treatments.
    [City of Hope]

    Press Release
    FEATURED EVENT

    European Society for Blood and Marrow Transplant (EBMT)

    March 19 – 23, 2022
    Prague, Czech Republic & Online

    > See All Events

    JOB OPPORTUNITIES

    Research Scientist – CAR T Cells

    BioNTech – Gaithersburg, Maryland, United States

    Research Technician – Placental Development

    Friedrich Miescher Institute for Biomedical Research – Basel, Switzerland

    Postdoctoral Associate – Cell Viability

    Singapore-MIT Alliance for Research and Technology (SMART) Centre – Singapore, Singapore

    Research Scientist – T Cell Stimulation

    Babraham Institute – Babraham, England, United Kingdom

    Postdoctoral Scientist – Cellular Immunology/T Cell Therapy

    TU Dresden – Dresden, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter